Combination of laser and light therapy versus laser and blood injection for inducing skin colour in white patches
Phase 2
Completed
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2019/08/020748
- Lead Sponsor
- Vamshi Krishna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 51
Inclusion Criteria
Patients with stable vitiligo lesions with less than 15-20% of BSA involvement.
Exclusion Criteria
Patients with unstable , universalis and mucosal vitiligo lesions.
Patients who have received any topical medications or systemic treatment during the last 2 months before starting the study.
Patients who had any contraindications to phototherapy exposure , e.g., history of presence of malignant or pre - malignant skin lesions.
Patients with keloids, hypertrophic scars, photosensitivity conditions and koebner phenomenon.
Pregnancy and Lactating females.
Patients with unrealistic expectation about the result after treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Two dermatologists will be asked to record the percentage of improvement (repigmentation) for each patient after completion of the treatment by comparing before and after digital photographs by a 5-point scale. <br/ ><br> <br/ ><br>Grade 0 (no repigmentation) <br/ ><br>Grade 1 (1%-5%) <br/ ><br>Grade 2 (6%-25%) <br/ ><br>Grade 3 (26%-50%) <br/ ><br>Grade 4 (51%-75%) <br/ ><br>Grade 5 (76%-100%) <br/ ><br>Â <br/ ><br>Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method The patients will also be asked at the final visit to rate the overall satisfaction as Visual assessment score(VAS ,0-10) ; <br/ ><br> <br/ ><br> 0 level defined as â??Not satisfied at allâ?? while a level of 10 will be defined as â??completely satisfiedâ??. <br/ ><br>Timepoint: 3 months